A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/48 (2006.01) A61P 7/04 (2006.01)
Patent
CA 2431986
Major bleedings induced by thrombolytic/fibrinolytic therapy, including intracranial haemorrhages, are treated by adminstering to a subject suffering from such bleedings an effective amount of activated coagulation factor VII (VIIa) or of a functional derivative thereof.
L'invention concerne des hémorragies importantes causées par une thérapie thrombolytique/fibrinolytique, dont des hémorragies intracraniennes, qui sont traitées par administration à un sujet d'une quantité efficace du facteur VII de coagulation activé (VIIa) ou d'un dérivé fonctionnel de ce dernier.
Heusel Gerhard
Skamira Cord
Stassen Jean Marie
Wienen Wolfgang
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Fetherstonhaugh & Co.
LandOfFree
Use of activated coagulation factor vii for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of activated coagulation factor vii for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of activated coagulation factor vii for treating... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1488786